Details for: CAPRELSA
Company: SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02378582 | CAPRELSA | VANDETANIB | 100 MG | TABLET | ORAL |
| 02378590 | CAPRELSA | VANDETANIB | 300 MG | TABLET | ORAL |
Summary Reports
Summary Basis of Decision
Summary Safety Review - Vascular Endothelial Growth Factor Receptor Inhibitors - Thrombotic Microangiopathy
Summary Safety Review - Vascular Endothelial Growth Factor Receptor Inhibitors - Thrombotic Microangiopathy
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.